JPRN-UMIN000026909
Recruiting
未知
Evaluation of the efficacy of daclatasvir+asunaprevir+beclabuvir for Japanese hepatitis C patients; a prospective study in real life settings. - The efficacy of daclatasvir+asunaprevir+beclabuvir for Japanese hepatitis C patients.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Toranomon Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •decompensated cirrhosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy and safety of daclatasvir and asunaprevir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000016181shonan kamakura general hospital30
Completed
Not Applicable
Efficacy and safety of daclatasvir and asunaprevir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000015247Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology350
Completed
Not Applicable
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infectiohemodialyzed patients with genotype 1 chronic hepatitis C infectionJPRN-UMIN000024227others130
Completed
Not Applicable
Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis Chemodialyzed patients with chronic hepatitis CJPRN-UMIN000016355Hokkaido University Hospital100
Active, not recruiting
Not Applicable
PH III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Inelgibles. Naives)EUCTR2011-005446-35-ESBristol-Myers Squibb International Corporation1,100